journal article·2025-04Open access

SNA·SMNP·CBE system: A novel integrative strategy for β-hemoglobinopathies gene therapy

Hongya Cheng, Wenqiao Hui, Hanyue Kang, Zhenni Shi, Jianlei Liu, Xin Wang, Fei Qi, Lin Mao, Huiqian Ding, Rongjian Hu, Nabila Begum, Daoqiang Lu, Dandan Chen, Xinyue Cheng, Miaomiao Wan, Dahai Liu, Hsian-Rong Tseng, Shoudong Ye, Xiaobin Xu, Baowei Zhang, Qian Ban

Nano Today· Volume 61

Abstract

Here, we developed and demonstrated a novel integrative system—Silica Nanorods (SNA) substrate cell capture combined with Supramolecular Nanoparticle (SMNP) delivery mediated CBE base editing (SNA·SMNP·CBE)—achieving the synchronization of CD34+HSPCs cell capture and gene editing for β-hemoglobinopathies. First, in vitro study shows it enables efficient and precise modification of BCL11A promoter in CD34+HSPCs, yielding the highly editing efficiency of 50.4 %, thus making an alternative strategy to conventional immunomagnetic cell separation and electroporation transfection system mediated CBE editing (IMS·EP·CBE). Then, we transplanted the edited human CD34+HSPCs into severe combined immunodeficiency (SCID) mice by using intraosseous injection strategy. When compared with conventional IMS·EP·CBE methods, our results showed that significantly higher human HBG expression in the bone marrow and peripheral blood of recipient mice, and long-term engraftment , evidenced from similar gene expression profiles to naïve CD34+HSPCs at 14 weeks. Conclusively, our integrative system—SNA·SMNP·CBE·intraosseous injection—offers an appealing novel way for the unique potential of gene therapy in the clinic application for β-hemoglobinopathies patients.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hemoglobinopathies and Related Disorders · CRISPR and Genetic Engineering · Parvovirus B19 Infection Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (50)

Show source-provided references
1. Modell · Bull. World Health Organ · 2008 · 86 · 48010.2471/BLT.06.036673 ↗
2. Piel · PLOS Med. · 2013 · 1010.1371/journal.pmed.1001484 ↗
3. Tanhehco · Transfus. Apher. Sci. · 2021 · 60
4. Venkatesan · Mol. Cell Biol. · 2020 · 41
5. Crossley · Trends Genet. · 2022 · 38 · 128410.1016/j.tig.2022.07.003 ↗
6. Sharma · N. Engl. J. Med. · 2023 · 389 · 82010.1056/NEJMoa2215643 ↗
7. Ataga · N. Engl. J. Med. · 2017 · 376 · 42910.1056/NEJMoa1611770 ↗
8. Vichinsky · N. Engl. J. Med. · 2019 · 381 · 50910.1056/NEJMoa1903212 ↗
9. Doerfler · J. Clin. Investig. · 2021 · 13110.1172/JCI146394 ↗
10. Brusson · Prog. Mol. Biol. Transl. Sci. · 2021 · 182 · 15310.1016/bs.pmbts.2021.01.025 ↗
11. Bhoopalan · Cytotherapy · 2023 · 25 · 26110.1016/j.jcyt.2022.08.003 ↗
12. Weber · Sci. Adv. · 2020 · 610.1126/sciadv.aay9392 ↗
13. Feng · Nature · 2022 · 610 · 78310.1038/s41586-022-05312-w ↗
14. Bauer · Science · 2013 · 342 · 25310.1126/science.1242088 ↗
15. Sankaran · Science · 2008 · 322 · 183910.1126/science.1165409 ↗
16. Masuda · Science · 2016 · 351 · 28510.1126/science.aad3312 ↗
17. Liu · Cell · 2018 · 17310.1016/j.cell.2018.03.080 ↗
18. Cardoso · Blood Cells Mol. Dis. · 2014 · 53 · 17610.1016/j.bcmd.2014.07.006 ↗
19. Martyn · Nat. Genet. · 2018 · 50 · 49810.1038/s41588-018-0085-0 ↗
20. M├®tais · Blood Adv. · 2019 · 3 · 337910.1182/bloodadvances.2019000820 ↗
21. Han · Eur. J. Pharmacol. · 2022 · 91810.1016/j.ejphar.2022.174788 ↗
22. Morrison · Nature · 2014 · 505 · 32710.1038/nature12984 ↗
23. Kondo · Annu Rev. Immunol. · 2003 · 21 · 75910.1146/annurev.immunol.21.120601.141007 ↗
24. Angelucci · Haematologica · 2014 · 99 · 81110.3324/haematol.2013.099747 ↗
25. Caocci · Am. J. Hematol. · 2017 · 92 · 130310.1002/ajh.24898 ↗
26. Omer-Javed · Cell · 2022 · 18510.1016/j.cell.2022.04.039 ↗
27. Gragert · N. Engl. J. Med. · 2014 · 371 · 33910.1056/NEJMsa1311707 ↗
28. Gorur · Blood Rev. · 2024 · 6310.1016/j.blre.2023.101137 ↗
29. Alessandrini · S Afr. Med. J. · 2019 · 109 · 6410.7196/SAMJ.2019.v109i8b.013910 ↗
30. Batista Napotnik · Bioelectrochemistry · 2021 · 14110.1016/j.bioelechem.2021.107871 ↗
31. Drysdale · Cell Stem Cell · 2021 · 28 · 19110.1016/j.stem.2021.01.001 ↗
32. Traxler · Nat. Med. · 2016 · 22 · 98710.1038/nm.4170 ↗
33. Lattanzi · Mol. Ther. · 2019 · 27 · 13710.1016/j.ymthe.2018.10.008 ↗
34. Ye · Proc. Natl. Acad. Sci. USA · 2016 · 113 · 1066110.1073/pnas.1612075113 ↗
35. Frangoul · Blood · 2020 · 136 · 310.1182/blood-2020-139575 ↗
36. Lattanzi · Sci. Transl. Med. · 2021 · 1310.1126/scitranslmed.abf2444 ↗
37. Dever · Nature · 2016 · 539 · 38410.1038/nature20134 ↗
38. Fitzhugh · Blood · 2017 · 130 · 194610.1182/blood-2017-03-772392 ↗
39. Porto · Nat. Rev. Drug Discov. · 2020 · 19 · 83910.1038/s41573-020-0084-6 ↗
40. Komor · Nature · 2016 · 533 · 42010.1038/nature17946 ↗
41. Nishida · Science · 2016 · 35310.1126/science.aaf7573 ↗
42. Wang · Angew. Chem. Int. Ed. Engl. · 2009 · 48 · 897010.1002/anie.200901668 ↗
43. Liu · Adv. Mater. · 2013 · 25 · 92210.1002/adma.201203826 ↗
44. Wang · Adv. Mater. · 2021 · 33
45. Ban · iScience · 2023 · 2610.1016/j.isci.2023.106446 ↗
46. Yang · Sci. Adv. · 2020 · 6
47. Ban · Nano Today · 2022 · 4710.1016/j.nantod.2022.101659 ↗
48. Z. Zhou, X. Sun, J. Cheng, Q. Ban, M. Guo.
49. Chou · Adv. Sci. · 2020 · 7 · 190343210.1002/advs.201903432 ↗
50. Liao · Nat. Commun. · 2023 · 14 · 20710.1038/s41467-022-35508-7 ↗